Cargando…
Bone Marrow Mesenchymal Stem Cells Inhibit Lipopolysaccharide-Induced Inflammatory Reactions in Macrophages and Endothelial Cells
Background. Systemic inflammatory response syndrome (SIRS) accompanied by trauma can lead to multiple organ dysfunction syndrome (MODS) and even death. Early inhibition of the inflammation is necessary for damage control. Bone marrow mesenchymal stem cells (BMSCs), as a novel therapy modality, have...
Autores principales: | Li, Dequan, Wang, Cong, Chi, Chuang, Wang, Yuanyuan, Zhao, Jing, Fang, Jun, Pan, Jingye |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746395/ https://www.ncbi.nlm.nih.gov/pubmed/27057093 http://dx.doi.org/10.1155/2016/2631439 |
Ejemplares similares
-
Lipopolysaccharide-activated macrophages regulate the osteogenic differentiation of bone marrow mesenchymal stem cells through exosomes
por: Song, Xiao, et al.
Publicado: (2022) -
The crosstalk between macrophages and bone marrow mesenchymal stem cells in bone healing
por: Wang, Yu-Hao, et al.
Publicado: (2022) -
Effect of lipopolysaccharide on the characteristics of endothelial progenitor cells from bone marrow in mice
por: LI, HAO, et al.
Publicado: (2014) -
Correction: The crosstalk between macrophages and bone marrow mesenchymal stem cells in bone healing
por: Wang, Yu-Hao, et al.
Publicado: (2022) -
Macrophages—bone marrow mesenchymal stem cells crosstalk in bone healing
por: Fan, Siyu, et al.
Publicado: (2023)